Literature DB >> 1551246

Natural history and control of perinatally acquired hepatitis B virus infection.

A S Lok1.   

Abstract

Maternal-infant transmission of hepatitis B virus (HBV) infection is estimated to account for 40-50% of HBV carriers in Chinese populations, but is uncommon among other ethnic groups. The high frequency of maternal-infant transmission among Chinese populations is related to the high prevalence of carrier mothers with replicative HBV infection. The natural course of perinatally acquired HBV infection consists of three phases: an initial phase of immune tolerance followed by a phase of immune clearance and then a non-replicative phase. The initial phase of immune tolerance which may last for several decades contributes to the poor response to interferon therapy. The high prevalence of carrier mothers with replicative infection mandates a combination of passive and active prophylaxis for the newborns.

Entities:  

Mesh:

Year:  1992        PMID: 1551246     DOI: 10.1159/000171343

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  18 in total

1.  Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission.

Authors:  Tomoko Takano; Hitoshi Tajiri; Satoyo Hosono; Ayano Inui; Jun Murakami; Kosuke Ushijima; Yoko Miyoshi; Yuri Etani; Daiki Abukawa; Mitsuyoshi Suzuki; Stephen Brooks
Journal:  J Gastroenterol       Date:  2017-02-09       Impact factor: 7.527

2.  Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation.

Authors:  G K Lau; P C Wu; R Liang; S T Yuen; W L Lim
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 3.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Authors:  C-K Hui; W W W Cheung; W-Y Au; A K W Lie; H-Y Zhang; Y-H Yueng; B C Y Wong; N Leung; Y-L Kwong; R Liang; G K K Lau
Journal:  Gut       Date:  2005-07-06       Impact factor: 23.059

5.  Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.

Authors:  Hai-Ying Lu; Zheng Zeng; Xiao-Yuan Xu; Nai-Lin Zhang; Min Yu; Wei-Bo Gong
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

6.  Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.

Authors:  Kentaro Matsuura; Yasuhito Tanaka; Shuhei Hige; Gotaro Yamada; Yoshikazu Murawaki; Masafumi Komatsu; Tomoyuki Kuramitsu; Sumio Kawata; Eiji Tanaka; Namiki Izumi; Chiaki Okuse; Shinichi Kakumu; Takeshi Okanoue; Keisuke Hino; Yoichi Hiasa; Michio Sata; Tatsuji Maeshiro; Fuminaka Sugauchi; Shunsuke Nojiri; Takashi Joh; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

7.  Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

Authors:  Si Hyun Bae; Seung Kew Yoon; Jeong Won Jang; Chang Wook Kim; Soon Woo Nam; Jong Young Choi; Boo Sung Kim; Young Min Park; Seiji Suzuki; Fuminaka Sugauchi; Masashi Mizokami
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

Review 8.  Telbivudine: a new treatment for chronic hepatitis B.

Authors:  Deepak N Amarapurkar
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

9.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

Authors:  H L-Y Chan; A Y Hui; M L Wong; A M-L Tse; L C-T Hung; V W-S Wong; J J-Y Sung
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 10.  Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.

Authors:  Changtai Zhu; Yulu Gao; Lihui Jiang; Baoqiong Ding; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.